Short Sellers Wary Of Biotech Stocks – Benzinga

Related ALXNYale University Is Bullish On ETFs & Alexion, Sold Twitter Last QuarterThe Dow Just Delayed A ‘Death Cross’The Vetr community has upgraded $ALXN to 4.5-Stars.(Vetr)Related CELGThe Historical Correlation Between Biotech Stocks And Interest Rates5 Biotechs With Catalysts Coming This WeekWeak Market? Don’t Tell That To Google, Celgene(Investor’s Business Daily)By and large, the number of shares short in the leading […]

Three Biotech Stocks Are Tumbling: VIVUS, Inc. (NASDAQ:VVUS …

Many individual investors have opted to invest in biotech ETFs and mutual funds. The XBI and SBIO funds have performed well because they focus more on small and mid-sized biotech companies. The IBB, which has emerged as something of a proxy for the industry for many investors, is weighted much more heavily to bigger, more proven biotech companies.The volatility of […]

Harness Biotech Stock Volatility with an Options Strategy :: The …

Harness Biotech Stock Volatility with an Options StrategyCompanies / BioTechAug 13, 2015 – 10:27 PM GMTBy: TLSReportVolatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That’s the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can you grow a portfolio if some of your more successful names […]

Hedge Funds Underperform In July, Lose -0.02%

Guest post courtesy of the Hennessee Group.
August 13, 2015 – New York, NY – Hennessee Group LLC announced today that the Hennessee Hedge Fund Index lost -0.02% in July (+2.94% YTD), while the S&P 500 gained +1.97% (+2.18% YTD), the Dow Jones Industrial Average rose +0.40% (-0.75% YTD), and the NASDAQ Composite Index jumped +2.84% (+8.28% YTD). Bonds were also […]

Top Oversold Biotech Stocks Include Mylan (NASDAQ: MYL …

With many investors starting to get more scared about China, scared about Europe and even scared about the coming interest rate hike cycle from the Federal Reserve, some smart money investors may be trying to figure out which stocks have already been heavily discounted to factor in bad news already. It may be impossible to ever know if a true […]

5 Biotechs Leerink Analysts Are Watching – Benzinga

Related FOLDMid-Morning Market Update: Markets Gain; Finish Line Beats Q1 ViewsMorning Market GainersRelated IPXLUS Stock Futures Signal Higher Start On Wall StreetImpax Announces Sale of Daraprim to Turing Pharmaceuticals AG , ~$55MAquinox’s Shares Shoot Up, Bladder Pain Drug in Focus(Zacks)In a recent report, analysts at Leerink shared their views on a ton of biotech stocks. Here is a look at […]

The Running Of The Bulltards: Milked and Bilked. Again.

Ponzi World (Over 3 Billion NOT Served): The Running Of The Bulltards: Milked and Bilked. Again.

The Running Of The Bulltards: Milked and Bilked. Again.Another “successful” Wall Street IPO pump and dump cycle endsRight on time, junk stocks are blowing off Shanghai StyleMW: August 10, 2015Revenueless Biotech Gains 2,700% In two days on 60x average volume.Gets CYNK’d at the end of […]

Aquinox Pharmaceuticals is up an insane 1,000% since Thursday and has been halted 6 times today

The last two trading sessions have been wild for Aquinox Pharmaceuticals.On Friday, shares spiked by up to 400% after the company reported earnings numbers, and positive trial results for a drug that treats bladder pain syndrome.On Monday, the stock surged by up to 365%. It’s now up more than 1000% from Thursday’s closing price of $1.79 per share.RelatedToday’s stock-market bubble is […]

Pipeline Updates Make These Three Biotech Stocks … – Benzinga

Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]

Don’t Forget These 5 Advantages You Hold Over Professional Investors

Written byJae Junfollow me onFacebookTwitter5 Common Excuses that Investors Believe 
The Uniqueness of the Stock Market
1. As a Small Investor You Are Able to Choose Your Expertise
2. You Can Go Against the Grain
3. You Are Not Judged Monthly, Quarterly or Yearly
4. You Can Afford to Be Patient
5. It’s Cheaper
Take Advantage of Your Advantages
“Don’t bother. The professionals are better than you and […]